China: Donations And Grants In China: Compliance Controls Beyond T&E

While travel and entertainment expenses have presented significant compliance challenges for life sciences companies operating in China, donations and grants can also pose notable compliance risks. China's escalated anti-corruption enforcement in recent years is well-publicized, and regulators have taken interest in grants and donations in the life sciences space. For example, in early 2015, the State Administration of Industry and Commerce ("SAIC"), which enforces commercial bribery regulations, published specific guidance on this issue for the pharmaceutical industry. More recently, the National Health and Family Planning Commission ("NHFPC"), China's regulator for the health care services sector, also enacted specific measures on donations for health care-related organizations. These trends suggest potential scrutiny from enforcement officials towards grants and donations, which may be areas that deserve additional attention from legal and compliance professionals in the life sciences sector.

I. New NHFPC Regulations on Donations

On October 20, 2015, the NHFPC published Measures for Administering the Receipt of Public Welfare Donations by Health and Family Planning Organizations ("New Measures"). Despite being announced in October, the New Measures became effective as of August 26, 2015, and replaced the previous measures enacted in 2007, entitled Interim Measures for the Administration of the Acceptance of Social Donations and Financial Aid by Health care and Health Institutions ("Old Measures").

The New Measures apply to donations received by hospitals, health care institutions and other health care organizations (e.g., medical associations, funds and charities) overseen by the NHFPC, regardless of whether the donations are made by domestic or foreign life sciences companies. The types of donations subject to the New Measures include funds and tangible property, though they are not necessarily exclusive. In particular, the New Measures provide detailed guidance on what donations would be considered appropriate, in part by expressly listing acceptable purposes for donations and prohibited types of donations. Additionally, the New Measures further require that health care institutions establish appropriate controls and procedures in accepting donations.

Although the New Measures technically apply to health and family planning institutions and organizations receiving donations, the detailed guidelines may indirectly impact how life sciences companies provide donations to those organizations and institutions. In turn, life sciences companies, both foreign and domestic, may want to ensure that their internal controls are consistent with the requirements of the New Measures.

Permitted and Prohibited Donations

Unlike the Old Measures, the New Measures expressly enumerate the types of donations that recipients are permitted to accept, which include donations for public health care education, training health care professionals, academic activities and research studies, discounting or waiving costs for medical treatments, and other non-profit programs. At the same time, it expressly prohibits acceptance of certain categories of donations, which include donations related to profit-seeking commercial activities, donations related to the procurement or purchase of products or services, donations where the donor has an interest in the economic benefits, intellectual property rights, research results or industry data of said donation, and donations that do not conform to laws and regulations or involve potential unfair competition and commercial bribery.

Interestingly, the prohibition against commercial bribery appears to create a link to the SAIC and local AICs. As noted above, while the New Measures apply directly to health care-related institutions, its list of expressly permitted and prohibited donations could potentially affect the AIC's interpretation in its commercial bribery enforcement actions.1

Procedural Requirements

The New Measures also set forth certain procedural requirements for donations, many of which are expansions of the Old Measures. For example, donations must still be documented via a written agreement, but the New Measures expressly require that certain information be specified, such as the type, quantity, quality and value of the donated items, the intention and purposes of the donation, restrictions on the management and use of the donated items, etc. The New Measures further provide clear requirements on the method of making donations, including, among other things, that monetary donations be made via bank transfers and that donations in the form of tangible property (e.g., products or equipment) undergo fair market valuation, preferably by a third-party appraiser.

The New Measures also appear to take a further step in requiring transparency. A donation recipient is required to publicize its written policies on accepting donations and disclose donations it has accepted, including the nature of the donated item, the value of such item, and how the item is used, on its website or via mainstream news media. Donation recipients must also report accepted donations in its annual financial statements, along with detailed explanations. Moreover, donation recipients are required to answer public inquiries about donations that they have accepted.

Notable Provisions that Require Further Clarification

The New Measures contain two provisions that are unclear, but may have particular relevance to life sciences companies in China. The first is a requirement that donations for training health care professionals, academic activities or scientific research may not designate the specific recipient or beneficiary. It is unclear, however, whether the scope of this restriction includes company sponsorships of specific health care professions ("HCPs") to attend academic meetings or professional trainings, or sponsorship of a particular principal investigator in conducting certain medical studies or clinical trials. The second requirement is an express prohibition against donations related to "profit-seeking commercial activities," which is not further defined. It is unclear whether this provision could be interpreted broadly to preclude donors from allowing display booths, spaces or other product promotion or marketing presence at an event.

Since its announcement, there has been little public information about enforcement actions pursuant to the New Measures, so it remains to be seen how the NHFPC will interpret these provisions. Nonetheless, some local hospitals and NHFPC-regulated entities have made public announcements stating that they will update their donation policies to comply with the New Measures.2 For the time being, however, life sciences companies should pay close attention to further guidance or enforcement signals from the NHFPC and AIC with respect to donations and grants.

II. Compliance Controls and Monitoring in Relation to Donations and Grants

While the ultimate impact of the New Measures is yet unclear, the underlying compliance risks nonetheless warrant attention. In recent years, pharmaceutical and medical devices companies have made significant efforts to enhance compliance controls and monitoring around travel and entertainment expenses. However, donations and grants are not devoid of FCPA risks and they can present unique compliance challenges. The most significant of those risks stem from involvement of a third party, which means limited control and transparency. In response, similar controls and monitoring for third parties should be undertaken, some of which include:

  • Ensure Clear Policies and Protocols

    While most companies' general anti-corruption and anti-bribery policies include provisions related to donations and grants, special attention to these issues may be warranted. For example, shielding involvement of sales and marketing functions from the company's internal decision-making process, particularly with respect to selecting recipients, can minimize potential quid pro quo considerations that may influence the decision (or the optics thereof). In fact, companies may want to limit the extent to which it designates eventual use of the donated funds or items to particular HCPs who would derive a benefit therefrom. Decisions on donations and grants often involve business considerations, and clear protocols can ensure that those decisions are subject to compliance controls.

  • Perform Due Diligence on the Recipient and Third-Party Intermediaries

    Due diligence should focus on uncovering any governmental relationships and assessing the reputation and appropriateness of the recipient or donee. Bribery risks can arise where the donation may be deemed to indirectly benefit a government official linked to the recipient organization. For example, if due diligence uncovers that the recipient is an organization established by an influential government official whose position or office happens to be relevant to the company's business, the company may wish to balance the potential risks and/or take additional steps to assess the appropriateness of the donation and implement enhanced compliance safeguards.

    Also, recipients, such as hospitals, medical associations and charitable organizations, are not impervious to fraud and misappropriation, as exemplified in accusations against the Red Cross Society of China regarding donations to aid victims of the devastating 2008 Sichuan earthquake. There may be additional reputational risks with providing donations to a recipient that is linked with improprieties and accusations of misconduct.

    Finally, employees might collude with the recipient or third-party intermediaries to engage in misconduct. Best practices would involve performing due diligence on any third-party intermediaries that are involved. Additionally, it may be worthwhile to understand the level of compliance controls employed by the intermediary to assess third-party compliance risks.

  • Ensure Appropriate Terms and Safeguards are Included in Donation, Grant, or Sponsorships Agreements

    The New Measures already require that the written donation agreements set out detailed terms of the donation. Accordingly, compliance terms should also be included. Such terms can set forth appropriate anti-bribery representations and warranties, a covenant from the recipient that the donated funds or items will only be used in accordance with the stipulated purpose and will not be reassigned or transferred, an obligation to provide any required supporting documents and information to show how the funds are actually used, and audit rights (to the extent practicable), among other provisions. Also, it is not uncommon in China for donation or grant recipients to informally solicit suggestions from company employees on the use of funds, including any preferences on selecting HCPs who may benefit from the donation, which can increase bribery risk. Hence, companies may also wish to clearly stipulate the company's detachment and independence from the use of the funds.

  • Post-Donation Monitoring and Verifications

    Similar to travel and entertainment expenses, securing supporting documentation and conducting follow-up verification are important steps towards detecting and deterring misappropriation and fraud in the context of donations and grants. Because third parties are involved, detailed supporting documentation and information tend to be more challenging to obtain. As noted above, companies may wish to establish controls and protocols for follow-up verifications and include contractual obligations for the recipient and/or intermediary to provide necessary supporting documentation and information in the written agreement.

Given the recent regulatory attention to donations and grants, particularly within China's heightened anti-bribery enforcement climate, compliance professionals in the life sciences sector may wish to pay particular attention to how donations and grants are being provided and enhance their compliance programs, where needed, to reduce compliance risks related to donations and grants.


1 As of the time of this article, the AIC has not published any cases instructive to this point and it remains unclear how the New Measures will influence AIC enforcement behavior.

2 On January 10, 2016, Peking University People's Hospital implemented a local policy regarding administering the receipt of non-profit donations, based on the New Measures. Similarly, on February 18, 2016, Chongqing Cancer Hospital implemented a local policy regarding administering the receipt of non-profit donations, based on the New Measures. On May 10, 2016, Tianjin Health and family Planning Commission announced on its website that the local districts/counties and hospitals should follow the New Measures.

3 See here and here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.